What Athena Diagnostics does

Athena Diagnostics, Inc. is a U.S. reference laboratory founded in 1988 and headquartered in Marlborough, Massachusetts, operating as a wholly-owned subsidiary of Quest Diagnostics (NYSE: DGX). The company specializes in genetic and diagnostic testing for neurological, endocrine, and renal conditions, offering a catalog of more than 400 tests that span Alzheimer's disease (ADmark evaluations), epilepsy panels, hereditary ataxia, Charcot-Marie-Tooth disease, hereditary spastic paraplegia, muscular dystrophy, myasthenia gravis autoantibodies, paraneoplastic syndromes (Recombx profiles), monogenic diabetes (MODY), polycystic kidney disease, and related neuromuscular and developmental disorders. Its technology stack combines proprietary genetic assays, reflexive testing algorithms, and a patent portfolio exceeding 100 issued U.S. patents covering core test methodologies. The lab is credentialed under CLIA (22D0069726), CAP (3733701), ISO 14001, and holds individual state clinical laboratory licenses in CA, MA, MD, NY, PA, and RI, alongside a Medicare provider number and Medicaid enrollment in ME, MA, and OH.\n\nAthena sells its services primarily to neurologists, endocrinologists, nephrologists, hospitals, reference labs, and genetic counselors through physician-order requisition forms, with sample collection handled via the Quest Diagnostics Patient Service Center network or via direct-to-patient saliva collection kits. The company monetizes through direct billing to in-network commercial insurers (Aetna, Anthem BCBS, Cigna, Harvard Pilgrim, Empire/Federal/Horizon BCBS variants, etc.), Medicare Part B (for non-molecular tests), Medicaid in enrolled states, and patient self-pay via the Advance Pay Program (20% cash discount on genetic tests). The Athena Alliance Program provides income-based financial assistance (broadened to 400% of federal poverty guidelines effective September 1, 2025). Supporting platforms include IntelliTest Manager (electronic ordering), AthenaInsight (variant re-investigation), eResults, AutoFax, Quanum Lab Services Manager, and pre-authorization concierge support for clinicians and patients.

Name

Athena Diagnostics

Legal name

Athena Diagnostics, Inc.

Website

https://athenadiagnostics.com

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Athena Diagnostics, a wholly-owned Quest Diagnostics subsidiary, operates a reference laboratory offering 400+ genetic and diagnostic tests for neurological, endocrine, and renal conditions, serving neurologists, endocrinologists, nephrologists, hospitals, and patients across the United States.

Ownership category

akta.pro rank

Product category

Clinical Reference Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

akta.pro secondary industries

Autoimmune, Allergy & Specialized Immunology Diagnostics (HLAHAAAK), Neuromuscular Medicine (ALS, Myasthenia, Neuropathy) (HLAKAIAD), Genetic & Rare Kidney Disease Clinics (HLAKAHAO)

Keywords

• Neurological diagnostic testing
• Genetic testing services
• Clinical reference laboratory
• Neurology genetic panels
• Alzheimer's diagnostic evaluation

Headquarters

HQ city

Worcester

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Laboratory Testing Services: Clinical laboratory testing services for neurological, endocrine, and renal conditions. Revenue generated through direct billing to insurance (in-network and out-of-network) and patient self-pay arrangements.
2. Commercial Insurance Billing: For in-network patients, services are billed directly to contracted insurance plans with no upfront patient charges. For out-of-network patients, claims are filed and patients may be billed for uncovered charges.
3. Medicare and Medicaid Billing: Medicare Part B billing for non-molecular tests in Massachusetts. Medicaid enrollment in Maine, Massachusetts, and Ohio. Hospital inpatient/outpatient Medicare claims are billed directly to Medicare.
4. Self-Pay and Advance Pay: Discounted cash payment option (20% discount) for patients paying out-of-pocket for genetic testing. Financial assistance through Athena Alliance Program for qualifying uninsured or underinsured patients.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels4 records

Core offering

Athena Diagnostics is a clinical reference laboratory providing more than 400 genetic and diagnostic tests for neurological, endocrine, and renal conditions. The company develops and commercializes proprietary panels for Alzheimer's disease (ADmark), muscular dystrophy, epilepsy, ataxia, hereditary spastic paraplegia, Charcot-Marie-Tooth disease, paraneoplastic syndromes, monogenic diabetes (MODY), polycystic kidney disease, and Rett syndrome. Services are ordered by physicians and delivered with results via AutoFax, eResults, Quanum Lab Services Manager, or mailed reports.

Product overview

Athena Diagnostics is a diagnostic testing laboratory offering a comprehensive menu of over 400 genetic and diagnostic tests for neurological, endocrine, and renal conditions. The company's portfolio centers on genetic testing panels for complex disorders including Alzheimer's disease (ADmark tests), epilepsy, ataxia, hereditary spastic paraplegia, Charcot-Marie-Tooth disease, and paraneoplastic syndromes. Test results are delivered through multiple platforms including AutoFax, eResults, and Quanum Lab Services Manager. Supporting services include AthenaInsight for variant re-investigation, IntelliTest Manager for test ordering, and the Athena Alliance Program for financial assistance. The company operates under CLIA certification and holds multiple state laboratory licenses across the United States.

Differentiator

Problem solved

Functional benefit

Products and services

• Diagnostic Testing Services Comprehensive genetic and diagnostic testing services for neurological, endocrine, and renal conditions, offering over 400 diagnostic tests including Alzheimer's disease evaluation, epilepsy panels, ataxia assessments, hereditary spastic paraplegia testing, and muscular dystrophy analysis. For physicians, neurologists, endocrinologists, nephrologists, hospitals, and reference laboratories.
• ADmark Alzheimer's Evaluation Comprehensive Alzheimer's disease diagnostic evaluation including ADmark Early Onset Alzheimer's Evaluation, ADmark PS-1 and PS-2 DNA sequencing tests, and ADmark Phospho-Tau/Total-Tau/Ab42 CSF analysis for symptomatic patients.
• Epilepsy Advanced Sequencing and CNV Evaluation Advanced genetic testing for epilepsy including sub-panels covering generalized absence, focal, febrile, myoclonic epilepsies, epileptic encephalopathy, developmental brain malformations, intellectual disability, neuronal ceroid lipofuscinosis, epilepsy with migraine, syndromic disorders, and infantile spasms.
• Ataxia Evaluation Suite Comprehensive ataxia evaluation including autosomal dominant, autosomal recessive, common repeat expansion, and supplemental recessive evaluations, plus ataxia-telangiectasia (ATM) DNA deletion and sequencing analysis.
• Hereditary Spastic Paraplegia (HSP) Evaluation Genetic evaluation for hereditary spastic paraplegia including comprehensive, common sporadic, complete dominant, common dominant, and complete recessive evaluations.
• CMT Advanced Evaluation Comprehensive evaluation for Charcot-Marie-Tooth disease including initial genetic assessment and complete comprehensive panels.
• Paraneoplastic Evaluation Paraneoplastic syndrome testing including NeoCerebellar Degeneration, NeoComplete, NeoEncephalitis, NeoSeM Basic, and NeoSensory Neuropathy profiles with Recombx autoantibody detection.
• Monogenic Diabetes (MODY) Evaluation Genetic testing for monogenic diabetes including 5-gene MODY evaluation, HNF4A (MODY1), HNF1A (MODY3), HNF1B (MODY5), CEL (MODY8), and neonatal diabetes mellitus evaluation.
• Complete PKD Evaluation Comprehensive evaluation for polycystic kidney disease including familial mutation evaluation and sequencing analysis.
• Complete Rett Syndrome Evaluation Comprehensive MECP2 testing including DNA sequencing and duplication/deletion analysis for Rett syndrome diagnosis.
• Complete SMA Evaluation Spinal muscular atrophy testing including reflexive evaluation, SMA Plus, SMN DNA sequencing, and carrier testing.
• Complete Ataxia Evaluation Comprehensive ataxia genetic testing covering autosomal dominant ataxia (SCA1, SCA3, SCA5, SCA6, SCA7, SCA8, SCA10, SCA13, SCA14), autosomal recessive ataxia, and Friedreich ataxia.
• AthenaInsight Variant Investigation Variant investigation and re-analysis service allowing clinicians to request re-analysis for previously reported genetic findings. Includes Family Insight Program forms for download.
• Test Results Delivery Platforms Multiple options for receiving test results including AutoFax (low-medium volume private/small group practice), Mailed Reports (all volumes), eResults (all volumes with secure colleague forwarding), and Quanum Lab Services Manager (medium-high volume physician practice and hospital/lab setting).
• IntelliTest Manager Test management tool for ordering and tracking diagnostic tests through the Athena Diagnostics system.
• Saliva Collection Kit Home-based saliva collection kit that can be shipped directly to patients for at-home genetic testing sample collection.
• Athena Alliance Program Financial assistance program offering reduced patient costs for genetic testing, with eligibility up to 400% of federally established income guidelines as of September 1, 2025.
• Advance Pay Program Cash payment option providing patients with a 20% discount when paying directly rather than through insurance for genetic testing.

Named customers10 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature14 records

Partnerships

One partnership is on record.

• Quest DiagnosticscoreOthersAthena Diagnostics is a subsidiary of Quest Diagnostics, utilizing the Quest Diagnostics Patient Service Center network for sample collection and maintaining shared infrastructure and laboratory resources.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• ARUP Laboratories: ARUP is a nonprofit reference laboratory that provides esoteric and specialty diagnostic testing across neurology, genetics, and metabolic disorders. It directly competes with Athena in neurological genetic testing and serves similar hospital and physician clients with complex specialty panels.
• Mayo Clinic Laboratories: Mayo Clinic Laboratories is a major reference laboratory offering specialty genetic and neurological testing through Mayo Clinic's clinical expertise. It competes directly with Athena in neurology, endocrinology, and rare disease genetic panels, serving similar specialist physician customers.
• GeneDx (formerly Sema4): GeneDx is a specialty clinical genomics company offering whole exome sequencing, rare disease panels, and neurological genetic testing. It competes directly with Athena's neurogenetic testing menu including epilepsy, ataxia, and neuromuscular disorder panels for pediatric and adult neurology customers.
• Ambry Genetics: Ambry Genetics (a Konica Minolta company) specializes in clinical genetic testing for hereditary cancer, neurology, and rare diseases. It competes with Athena on neurological and rare disease genetic panels with overlapping reflexive testing algorithms serving similar specialist clinicians.
• PreventionGenetics: PreventionGenetics is a clinical DNA testing laboratory offering comprehensive genetic testing across neurology, neuromuscular disorders, and rare diseases. It overlaps with Athena's test menu in areas such as ataxia, epilepsy, CMT, and other neurogenetic conditions.
• Blueprint Genetics: Blueprint Genetics (now part of Quest Diagnostics) specializes in rare disease genetic testing with a focus on neurological, cardiovascular, and metabolic disorders. As a Quest-owned entity, it is a sibling company to Athena with overlapping test menus in neurological genetics.

Broad incumbents

• Labcorp Genetics: Labcorp is one of the largest U.S. clinical laboratory networks offering extensive genetic and specialty testing. While it operates at a much broader scale than Athena, it directly competes on neurological genetic panels, neuromuscular testing, and Alzheimer's biomarker services.
• Quest Diagnostics: Quest Diagnostics is Athena's parent company and the largest U.S. clinical laboratory. While Athena is a focused subsidiary, Quest's broader genetic and specialty testing portfolio competes in adjacent areas including BRCA, pharmacogenomics, and general molecular diagnostics.

Emerging players

• C2N Diagnostics: C2N Diagnostics is an emerging specialty diagnostics company offering blood-based Alzheimer's biomarker testing (PrecivityAD). It represents a potential substitute modality for Athena's CSF-based ADmark Alzheimer's evaluations, particularly as blood-based biomarkers gain traction.
• Quanterix: Quanterix provides ultra-sensitive blood-based biomarker testing using Simoa technology, including neurology and neurodegeneration assays. It represents an emerging alternative diagnostic platform that could compete with Athena's neurology biomarker testing over time.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/athena-diagnostics

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Athena Diagnostics